11:26 AM EST, 02/25/2026 (MT Newswires) -- WELL Health Technologies ( WHTCF ) this week highlighted patient metrics for its Canadian clinic network, with a record 4.3 million patient visits in 2025, a 37% increase, including 10% organic expansion.

According to Stifel Canada analyst Justin Keywood, who has a buy rating and C$9.00 price target on the stock, these metrics are indicative of a strong, upcoming fiscal fourth quarter, to be reported around March 12.

Keywood is forecasting $387 million in sales, up 67% YoY, (in-line with consensus) and adj. EBITDA $57 million. Flu cases were at a record level in the fourth quarter, up ~50% and supporting increased doctor visits, indicated in WELL's record patient visits, he notes.

"The sector backdrop for Health-Tech remains challenged with certain U.S. peers under pressure, but we see WELL's business model as relatively insulated, given its services platform, empowered by technology/AI."

WELL's valuation reflects streamlining efforts and is still relatively low valuation: 1x sales, vs. peers 1.3x.. But constructive quarters ahead and divestures, paired with M&A could re-rate shares and close the valuation gap, Keywood writes.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 3.96, Change: +0.04, Percent Change: +1.02